John Maynard

1.6k total citations
47 papers, 823 citations indexed

About

John Maynard is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, John Maynard has authored 47 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Clinical Biochemistry, 18 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Surgery. Recurrent topics in John Maynard's work include Advanced Glycation End Products research (18 papers), Diabetes Management and Research (11 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). John Maynard is often cited by papers focused on Advanced Glycation End Products research (18 papers), Diabetes Management and Research (11 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). John Maynard collaborates with scholars based in United States, United Kingdom and Canada. John Maynard's co-authors include Trevor J. Orchard, M. N. Ediger, Nathaniel I. Matter, Baqiyyah Conway, Mark Rohrscheib, Stuart A. Chalew, Robert E. Ratner, Vanita R. Aroda, Stephen Fernandez and James M. Hempe and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Neurology and Diabetes Care.

In The Last Decade

John Maynard

47 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Maynard United States 17 320 306 215 92 89 47 823
Asako Yamamoto Japan 15 93 0.3× 38 0.1× 215 1.0× 51 0.6× 52 0.6× 67 771
Engın Güney Türkiye 16 294 0.9× 22 0.1× 243 1.1× 47 0.5× 114 1.3× 52 884
Takahisa Tanikawa Japan 12 106 0.3× 136 0.4× 73 0.3× 47 0.5× 54 0.6× 27 646
Ching‐Jung Hsieh Taiwan 18 475 1.5× 49 0.2× 145 0.7× 114 1.2× 34 0.4× 26 814
H. Christian Volz Germany 15 112 0.3× 531 1.7× 199 0.9× 44 0.5× 64 0.7× 20 1.2k
Makoto Ohara Japan 15 437 1.4× 57 0.2× 261 1.2× 149 1.6× 37 0.4× 74 869
Sophie Bernard Canada 24 686 2.1× 56 0.2× 612 2.8× 100 1.1× 60 0.7× 74 1.7k
Meika A. Fang United States 19 51 0.2× 40 0.1× 175 0.8× 55 0.6× 116 1.3× 32 866
Hiroko Hara Japan 18 178 0.6× 14 0.0× 641 3.0× 37 0.4× 189 2.1× 58 1.1k
Noriko Kishimoto Japan 14 64 0.2× 65 0.2× 161 0.7× 9 0.1× 32 0.4× 22 675

Countries citing papers authored by John Maynard

Since Specialization
Citations

This map shows the geographic impact of John Maynard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Maynard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Maynard more than expected).

Fields of papers citing papers by John Maynard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Maynard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Maynard. The network helps show where John Maynard may publish in the future.

Co-authorship network of co-authors of John Maynard

This figure shows the co-authorship network connecting the top 25 collaborators of John Maynard. A scholar is included among the top collaborators of John Maynard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Maynard. John Maynard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Orchard, Trevor J., Marquis Hawkins, Baqiyyah Conway, et al.. (2020). Skin intrinsic fluorescence scores are a predictor of all-cause mortality risk in type 1 diabetes: The Epidemiology of Diabetes Complications study. Journal of Diabetes and its Complications. 35(2). 107770–107770. 4 indexed citations
2.
Eaton, Charles B., et al.. (2017). Sex differences in the association of skin advanced glycation endproducts with knee osteoarthritis progression. Arthritis Research & Therapy. 19(1). 36–36. 14 indexed citations
3.
Roshandel, Delnaz, Ronald Klein, Barbara E.K. Klein, et al.. (2016). New Locus for Skin Intrinsic Fluorescence in Type 1 Diabetes Also Associated With Blood and Skin Glycated Proteins. Diabetes. 65(7). 2060–2071. 7 indexed citations
4.
Eny, Karen, Trevor J. Orchard, Rachel G. Miller, et al.. (2015). Caffeine Consumption Contributes to Skin Intrinsic Fluorescence in Type 1 Diabetes. Diabetes Technology & Therapeutics. 17(10). 726–734. 16 indexed citations
5.
Stoner, Julie A., et al.. (2015). Epidemiology of Dysglycemia in Pregnant Oklahoma American Indian Women. The Journal of Clinical Endocrinology & Metabolism. 100(8). 2996–3003. 10 indexed citations
6.
Nunley, Karen A., Christopher M. Ryan, Trevor J. Orchard, et al.. (2015). White matter hyperintensities in middle-aged adults with childhood-onset type 1 diabetes. Neurology. 84(20). 2062–2069. 49 indexed citations
7.
Russ, David W., et al.. (2015). Dietary HMB and β-alanine co-supplementation does not improve in situ muscle function in sedentary, aged male rats. Applied Physiology Nutrition and Metabolism. 40(12). 1294–1301. 12 indexed citations
8.
Hull, Edward L., et al.. (2014). Noninvasive skin fluorescence spectroscopy for detection of abnormal glucose tolerance. Journal of Clinical & Translational Endocrinology. 1(3). 92–99. 6 indexed citations
9.
Cleary, Patricia A., Barbara H. Braffett, Trevor J. Orchard, et al.. (2013). Clinical and Technical Factors Associated with Skin Intrinsic Fluorescence in Subjects with Type 1 Diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabetes Technology & Therapeutics. 15(6). 466–474. 42 indexed citations
10.
Maynard, John, et al.. (2013). Advanced Glycation Endproducts in Children with Diabetes. The Journal of Pediatrics. 163(5). 1427–1431. 19 indexed citations
12.
Orchard, Trevor J., Timothy J. Lyons, Patricia A. Cleary, et al.. (2013). The Association of Skin Intrinsic Fluorescence With Type 1 Diabetes Complications in the DCCT/EDIC Study. Diabetes Care. 36(10). 3146–3153. 48 indexed citations
13.
Maynard, John, et al.. (2013). Comparison of SCOUT DS, the ADA Diabetes Risk Test and Random Capillary Glucose for Diabetes Screening in At-Risk Populations. Canadian Journal of Diabetes. 37. S78–S78. 1 indexed citations
15.
Alam, Mary Kathleen, et al.. (1999). Measurement of pH in Whole Blood by Near-Infrared Spectroscopy. Applied Spectroscopy. 53(3). 316–324. 16 indexed citations
16.
Alam, Mary Kathleen, Thomas M. Niemczyk, John Maynard, et al.. (1998). Characterization of pH Variation in Lysed Blood by Near-Infrared Spectroscopy. Applied Spectroscopy. 52(3). 393–399. 14 indexed citations
17.
Alam, Mary Kathleen, et al.. (1996). <title>Near-infrared spectroscopy of lysed blood: pH effects</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 2680. 146–155. 2 indexed citations
19.
Maynard, John. (1988). Enucleated parotid tumours. British journal of surgery. 75(8). 764–766. 6 indexed citations
20.
Maynard, John. (1965). Recurrent parotid enlargement. British journal of surgery. 52(10). 784–789. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026